Table 1

Results of a CE analysis among subpopulations with various health states

Total cost (2017 US$)Total QALYs gainedICER (cost [$] per QALY)
No complications
 Moderate (HbA1c <8.5%)49,2004.13510,000
 Stringent (HbA1c <7.5%)52,1004.423
 Incremental*2,9000.288
Microvascular complications
 Moderate (HbA1c <8.5%)63,6003.72819,600
 Stringent (HbA1c <7.5%)68,3003.966
 Incremental4,7000.238
Angina history
 Moderate (HbA1c <8.5%)46,3003.21582,400
 Stringent (HbA1c <7.5%)49,2003.250
 Incremental2,9000.035
MI history
 Moderate (HbA1c <8.5%)15,6001.746266,800
 Stringent (HbA1c <7.5%)18,0001.755
 Incremental2,4000.009
CHF history
 Moderate (HbA1c <8.5%)29,1001.559 336,000
 Stringent (HbA1c <7.5%)31,4001.565
 Incremental2,3000.007
Stroke history
 Moderate (HbA1c <8.5%)123,5002.968 104,100
 Stringent (HbA1c <7.5%)130,2003.033
 Incremental6,7000.065
Two macrovascular complications
 Moderate (HbA1c <8.5%)47,0001.434658,000
 Stringent (HbA1c <7.5%)49,7001.438
 Incremental2,7000.004
Three macrovascular complications
 Moderate (HbA1c <8.5%)51,1001.1081,365,600
 Stringent (HbA1c <7.5%)53,6001.110
 Incremental2,5000.002
  • * Incremental: stringent–moderate.